Bone Biologics Corporation (BBLG)
NASDAQ · Healthcare
Bone Biologics Corporation Operating Income 2019–2020
Bone Biologics Corporation annual/quarterly operating income history and growth rate from 2019 to 2021. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Bone Biologics Corporation operating income for the quarter ending March 31, 2021 was -180924, a 46.79% decrease year-over-year.
- Bone Biologics Corporation annual operating income for 2020 was -825014, a 66.29% decrease from 2019.
- Bone Biologics Corporation annual operating income for 2019 was -2.4 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Bone Biologics Corporation Operating Income — FAQ
Bone Biologics Corporation (BBLG) operating income over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
What is Bone Biologics Corporation's operating income?
Bone Biologics Corporation (BBLG) reported operating income of -$825,014 for fiscal 2020.
Where can I see BBLG's operating income history?
The chart and table above show Bone Biologics Corporation's operating income by year and by quarter, including the growth rate.